- Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger
- Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
- Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
- Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
- Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
- Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
- Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
- Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
More ▼
Key statistics
As of last trade, Pyxis Oncology Inc (PYXS:NSQ) traded at 2.94, 117.78% above the 52 week low of 1.35 set on Nov 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.18 |
---|---|
High | 3.18 |
Low | 2.92 |
Bid | 2.90 |
Offer | 2.97 |
Previous close | 2.94 |
Average volume | 1.39m |
---|---|
Shares outstanding | 58.89m |
Free float | 47.20m |
P/E (TTM) | -- |
Market cap | 173.13m USD |
EPS (TTM) | -1.39 USD |
Data delayed at least 15 minutes, as of Jul 02 2024 21:00 BST.
More ▼